The basic human need to look young has led to many concepts in facial rejuvenation. One such concept is the adaptation of platelet-rich plasma (PRP) for dermatologic uses. 1 PRP was originally developed to improve healing in orthopedic and dental surgery, but is now used in plastic surgery via injection for wound healing and hair growth. 2, 3 The next horizon is the adaptation of PRP for topical uses in cosmetic formulations.
(TGF-b1, TGFb2), vascular endothelial growth factor (VEGF), and epithelial growth factor (EGF). 5 These growth factors are found within a normal clot composed of fibrin, fibronectin, and vitronectin, which are cell adhesion molecules required for cell migration, as seen in wound healing. 6 Cellular mitogenesis and angiogenesis are both upregulated by PRP, making it useful in facial rejuvenation. 7 Autologous PRP is obtained from freshly drawn blood from the patient with an added anticoagulant and the sample then experiences a series of two centrifugation (spin) steps. 8 The first spin, known as the hard spin, separates the red blood cells from the plasma containing the platelets, white blood cells, and clotting factors. Three layers result from the hard spin: an upper layer containing platelets and white blood cells, a middle layer known as the buffy coat containing white blood cells, and a bottom layer containing red blood cells. The red blood cell layer is removed and discarded. The second spin, known as the soft spin, separates the platelet-rich plasma in the bottom of the tube from the platelet-poor plasma (PPP) in the top of the tube by removing more red blood cells. 9 Proper preparation and centrifuge technique is critical to obtaining high quality active PRP. 10 The literature has pointed to some preparations of PRP having a lack of biological effect which may be due to poor PRP processing or inadequate standard laboratory centrifuges that cannot properly prepare PRP rather than the specialized FDA cleared equipment with validated processes. 4 Platelet-rich plasma is autologous, thus concerns about immune rejection are a nonissue. 11 Growth factors function by activating a cytoplasmic signal that promotes normal gene expression. PRP contains the same materials present in the blood stream that induce clotting, except in higher concentration. 12 Platelet-rich plasma works through degranulation of the alpha granules in platelets, which contain the growth factors. It is ideal to collect PRP in an anticoagulated state for the growth factors to remain active explaining the need to draw the blood into a tube containing sodium citrate. 13 The biologically active cellular components such as the growth factors as preserved within the platelet when the platelet is held in an inactive state; premature degranulation does not occur, and therefore the cellular components are held within the protective enclosure of the platelet. 14 Upon activation of the platelet, the granules then fuse to the cell membrane, the degranulation process, activating the secretory growth factors, which bind to the transmembrane receptors of target cells, such as mesenchymal stem cells, fibroblasts, endothelial cells, and epidermal cells. 15 This binding activates intracellular signal proteins that express a gene sequence directing cellular proliferation, collagen synthesis, extracellular matrix formation, and numerous other pathways to promote healing and repair processes. 16 Damaged platelets with degraded or not viable cellular components are incapable of inducing this response. 17 The current pilot study examined the use of an autologously sourced PRP added to a preservative cosmetic base and applied twice daily to the face following electroporation for 8 weeks. Visual, photographic, histologic, immunohistochemical, and molecular qPCR data were obtained to better understand the role of topicaladministered PRP in facial rejuvenation.
| ME THODS
Twenty (20) healthy female and male subjects 30-60 years of age were enrolled in this single-site, investigator blinded, vehicle-controlled split-face study to evaluate the effect of a PRP-containing serum on facial photoaging. Subjects who signed consent and met all inclusion criteria and none of the exclusion criteria were enrolled at the baseline visit (Allendale Institutional Review Board, Old Lyme CT). Subjects were asked to continue their self-selected cleanser and nonmedicated facial cosmetics throughout the 8-
week study. Subjects were randomized to apply the PRP-containing serum to the right or left face and the serum alone to the opposite side of the face.
Dermatologist investigator and subject assessments for efficacy and tolerability were conducted on a 5-point ordinal scale (0 = none, 1 = minimal, 2 = mild, 3 = moderate, and 4 = severe) separately for each cheek. The following efficacy parameters were assessed: dryness, lack of tactile smoothness, lack of visual smoothness, lack of softness, lack of luminosity, lack of radiance, lack of firmness, poor skin texture, fine facial lines, wrinkles, poor skin tone, mottled hyperpigmentation, and overall appearance. Tolerability was assessed in terms of itching, stinging, burning, redness, and swelling.
Transepidermal water loss (TEWL) was performed from the right and left cheeks (Cyberderm, Broomall, PA) and Visia CR 4.3 (Canfield Scientific) photography of the front, right, and left sides of the face were completed before any treatments as baseline documentation.
All these activities were repeated at week 4 and week 8. (Table 1 ). Samples form subjects 2 and 4, produced samples that did not produce threshold counts; consequently, a fold change could not be determined.
| RE SULTS
The PRP + serum formulation was evaluated for PRP stability as the effective duration of blood-derived products has always been a limiting factor for topical application (Figure 3 ). Intact PDGF was identified in the 4 degree Celsius constantly refrigerated preservative serum 90 days after preparation. This was an important finding to allow further development of topical PRP cosmetics. Additional studies are underway, including a follow-on publication detailing long-term platelet stability.
| D ISCUSS I ON
There remains a paucity of controlled, randomized, blinded studies to evaluate the efficacy of topically applied PRP products for facial rejuvenation. This study was intended to address this knowledge gap. One of the biggest challenges in topical PRP use is the need to stabilize the blood product in a vehicle that provides excellent esthetic properties. Part of this project was to develop a serum suitable for PRP use with an appropriate tolerability profile. No tolerability issues arose and the serum demonstrated 90-day stability.
A traditional cosmetic serum is not suitable for use with PRP because commonly used preservatives will destroy the platelets. The study serum contained the preservatives honeysuckle extract and O-cymen-5-OL, which is an antifungal. In addition, the PRP requires a nutrient source and proper buffer system to maintain pH. Glucose, sodium chloride, sodium citrate, sodium acetate, sodium bicarbonate, potassium phosphate, potassium chloride, and magnesium The subjects applied the PRP + serum twice daily for 8 weeks.
It appears this application period was insufficient to achieve statis- Another challenge for topical PRP products is the penetration of the proteins into the epidermis, since the epidermis is uniquely designed to minimize protein penetration. This challenge was overcome using a hand-held electroporation device, which applied an electromagnetic field to the skin surface in order to increase permeability.
This research successfully addressed several of the topical PRP product challenges to include delivery and penetration; however, more research is needed to obtain a better idea of the duration of application required for optimal clinical benefits. PRP has proven to be an effective additive therapy for the healing of tendons, dental bone grafts, facial cosmetic surgery, and diabetic ulcers. [18] [19] [20] Its utility in dermatology should be promising, but more research is needed to overcome the challenging attributes of topical applications. 21 Topical PRP treatment may have translational applications in postprocedure applications for laser resurfacing, microneedling, radiofrequency tissue tightening, and dermabrasion. 
| SUMMARY

